These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16895799)

  • 1. Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cells.
    Bourdon E; Loreau N; Lagrost L; Davignon J; Bernier L; Blache D
    Free Radic Biol Med; 2006 Sep; 41(5):786-96. PubMed ID: 16895799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.
    Borradaile NM; de Dreu LE; Wilcox LJ; Edwards JY; Huff MW
    Biochem J; 2002 Sep; 366(Pt 2):531-9. PubMed ID: 12030847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
    Plummer MR; Hasty AH
    J Nutr Biochem; 2008 Oct; 19(10):664-73. PubMed ID: 18280133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells.
    Mitmesser SH; Carr TP
    J Nutr Biochem; 2005 Mar; 16(3):178-83. PubMed ID: 15741053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
    Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical protective effect of aminoguanidine toward low-density lipoprotein oxidation: inhibition of apolipoprotein B fragmentation without preventing its carbonylation. Mechanism of action of aminoguanidine.
    Jedidi I; Thérond P; Zarev S; Cosson C; Couturier M; Massot C; Jore D; Gardès-Albert M; Legrand A; Bonnefont-Rousselot D
    Biochemistry; 2003 Sep; 42(38):11356-65. PubMed ID: 14503886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein apolipoprotein B production differs between laboratory opossums exhibiting high and low lipemic responses to dietary cholesterol and fat.
    Kushwaha RS; VandeBerg JF; Rodriguez R; Chan J; VandeBerg JL
    Metabolism; 2005 Aug; 54(8):1075-81. PubMed ID: 16092058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
    Pau E; He Y; Lougheed M; Steinbrecher UP
    Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.
    Thompson A; Danesh J
    J Intern Med; 2006 May; 259(5):481-92. PubMed ID: 16629854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.
    Marcovina S; Packard CJ
    J Intern Med; 2006 May; 259(5):437-46. PubMed ID: 16629849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
    Dashti N
    J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oxidation on the structure and stability of human low-density lipoprotein.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.